tirzepatide available in pill form vs. Semaglutide: What You Should Know The dual Why Isn't There Oral Tirzepatide?

For instance, post hoc analyses from SURMOUNT-1 through SURMOUNT-4 [73] and from across the SURPASS program [74] showed that weight reduction with tirzepatide was neither solely nor fully associated with reported gastrointestinal adverse events, challenging the traditional assumption that nausea and vomiting are significant mediators of weight reduction

& Cohen, N

Subcutaneous injection into the abdomen, thigh, or upper arm requires minimal technique

Their birth control effectiveness decreases

This added pathway is why many clinicians are beginning to view it as the next phase of metabolic therapy, especially for patients who have plateaued